Date of publication: 2017-08-23 06:52
Department of Human Services data from the Medicare Benefits Schedule (MBS) and the Pharmaceutical Benefits Scheme (PBS), available from the 95 and Up Study, were also used in the analyses.
In order to fulfil this objective, the study aimed to determine the distribution of injury severity for hospitalised childhood injury in Australia describe the number, demographic characteristics, injury characteristics and outcomes of children who were hospitalised as a result of injury in Australia identify any temporal changes in the characteristics or severity of childhood injury resulting in hospitalisation and determine the type of hospitals where children with severe injury are treated and the incidence of transfer to other hospitals for higher level of care.
This project aims to examine perinatal outcomes of women who intend to give birth in different settings: birth centres, primary maternity units, at home and in hospital labour wards. The study will also evaluate whether place of birth has an influence on the diagnosis and outcome of congenital anomalies, and examine fetal growth parameters in relation to place of birth. Records from the NSW Perinatal Data Collection, Admitted Patient Data Collection, Register of Congenital Conditions, Perinatal Death Reviews, ABS mortality data and the Registry of Births, Deaths and Marriages death registration data will be linked for the period 7556-7559.
The high incidence of preventable adverse events and deaths in hospitals has triggered initiatives to improve the quality of care of acutely ill patients. These initiatives include the introduction of medical emergency teams (MET), outreach services or rapid response teams (RRT). These aim to identify seriously ill patients earlier in order to activate a timely and appropriate response and consequently improve patient outcomes.
Findings from this study will be used to develop a computer simulation model of invasive cervical cancer which will help to assess possible strategies for cervical screening after the introduction of human papillomavirus (HPV) vaccination against cervical cancer in various settings. The study will provide data to explicitly simulate treatment pathways in the Australian context. This will enable accurate calculation of invasive cancer treatment costs in cost-effectiveness assessments of screening alternatives. In addition, it will enable prediction of the long-term impact of HPV vaccination on the distribution of patients across treatment pathways and the long term impact of vaccination on cervical cancer treatment costs.
The findings will make an important contribution to knowledge regarding the factors and processes underlying Indigenous disadvantage they will inform current policy debates regarding the best approaches for addressing this disadvantage and will benefit the community by targeting effort to improve indigenous health, in particular hospital care of chronic diseases.
The aim of this study was to determine whether the higher than expected numbers of cancers reported at the Kooragang terminal in the preliminary study reflects a true increase when compared to the control cohorts of two reference populations.
7) Calculate the direct and indirect effectiveness of currently available childhood vaccinations at a population level and in at-risk populations, identify factors associated with vaccine effectiveness, and compare estimates over time and between NSW and WA.